Aurora Private Wealth Inc. Purchases Shares of 16,836 UnitedHealth Group Incorporated (NYSE:UNH)

Aurora Private Wealth Inc. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 16,836 shares of the healthcare conglomerate's stock, valued at approximately $8,818,000. UnitedHealth Group accounts for 2.3% of Aurora Private Wealth Inc.'s investment portfolio, making the stock its 5th largest holding.

A number of other large investors have also made changes to their positions in the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $32,000. Institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

UNH traded down $4.80 on Monday, hitting $303.75. 9,010,516 shares of the stock were exchanged, compared to its average volume of 7,565,859. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $275.54 billion, a price-to-earnings ratio of 12.72, a PEG ratio of 1.48 and a beta of 0.45. The business has a 50-day moving average of $324.99 and a two-hundred day moving average of $447.02.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on UNH shares. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. HSBC reaffirmed a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Mizuho dropped their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Wolfe Research reduced their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $415.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.